Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and …

J Gaertner, W Siemens, JJ Meerpohl, G Antes… - bmj, 2017 - bmj.com
Objective To assess the effect of specialist palliative care on quality of life and additional
outcomes relevant to patients in those with advanced illness. Design Systematic review with …

Quality of life in “chronic” cancer survivors: a meta-analysis

J Firkins, L Hansen, M Driessnack… - Journal of Cancer …, 2020 - Springer
Purpose Cancer survivors are now living longer giving rise to a new concept—chronic
cancer as survivors continue to face long-term consequences of cancer and its treatment …

[HTML][HTML] General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European …

S Nolte, G Liegl, MA Petersen, NK Aaronson… - European journal of …, 2019 - Elsevier
Abstract Objective The European Organisation for Research and Treatment of Cancer
(EORTC) QLQ-C30 health-related quality of life questionnaire is one of the most widely used …

[HTML][HTML] Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

JM Giesinger, FLC Loth, NK Aaronson… - Journal of clinical …, 2020 - Elsevier
Objective The objective of this study was to establish thresholds for clinical importance
(TCIs) for the five functioning and nine symptom scales of the European Organisation for …

[HTML][HTML] Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

P Gasser, D Holstein, Y Michel, R Doblin… - The Journal of …, 2014 - journals.lww.com
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine
safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients …

[HTML][HTML] Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized …

AS Mansfield, A Każarnowicz, N Karaseva, A Sánchez… - Annals of oncology, 2020 - Elsevier
Background The addition of atezolizumab to carboplatin and etoposide (CP/ET) significantly
improved progression-free and overall survival for patients with extensive-stage small-cell …

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or …

JJ Grob, MM Amonkar, B Karaszewska… - The Lancet …, 2015 - thelancet.com
Background In the COMBI-v trial, patients with previously untreated BRAF Val600Glu or
Val600Lys mutant unresectable or metastatic melanoma who were treated with the …

[HTML][HTML] Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry

H Schrezenmeier, P Muus, G Socié, J Szer… - …, 2014 - ncbi.nlm.nih.gov
Paroxysmal nocturnal hemoglobinuria is a rare, acquired disease associated with hemolytic
anemia, bone marrow failure, thrombosis, and, frequently, poor quality of life. The …

Quality of life and anxiety in women with breast cancer before and after treatment

RR Villar, SP Fernández, CC Garea… - … latino-americana de …, 2017 - SciELO Brasil
Objectives: to determine the quality of life and anxiety in patients with breast cancer and the
changes they experience after treatments. Method: prospective study. Breast cancer …

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients

R Scherber, AC Dueck, P Johansson… - Blood, The Journal …, 2011 - ashpublications.org
Symptomatic burden in myeloproliferative neoplasms is present in most patients and
compromises quality of life. We sought to validate a broadly applicable 18-item instrument …